Ligand induced conformational states of the 5-HT1A receptor

被引:39
|
作者
Sylte, I [1 ]
Bronowska, A
Dahl, SG
机构
[1] Univ Tromso, Fac Med, Inst Med Biol, Dept Pharmacol, N-9037 Tromso, Norway
[2] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland
关键词
G-protein coupled receptor; molecular dynamics; receptor activation; conformational changes; ligand induced;
D O I
10.1016/S0014-2999(01)00860-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been shown that G-protein coupled receptors have seven transmembrane alpha -helices, but the structural changes occurring in a G-protein coupled receptor as a response on agonist stimulus and the molecular events leading to blockade of the signal transduction by antagonists are not well understood. In the present study, the AMBER 5.0 force field was used for comparative molecular dynamics simulations of a 5-HT1A receptor model in the absence of ligand, in complex with a 5-HT1A receptor agonist (R)-8-hydroxy-2-(di-n-propylamino)tetralin [(R)-8-OH-DPAT], in complex with a selective 5-HT1A receptor antagonist (S)-N-rert-butyl-3-[4-(2-methoxyphenyl)piperazin-1-yl ]-2-phenylpropanamide [(S)-WAY100135], and in complex with the partial agonist, buspirone. In the simulations, the agonist induced larger conformational changes into transmembrane helix 3 and 6 than into the other helices, while the main conformational differences between the agonist bound receptor and the antagonist bound receptor were in transmembrane helix 5 and 6. During the simulations, all the three ligands constrained the helical movements compared to those observed in the receptor without any ligand. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [41] The 5-HT1A receptor knockout mouse and anxiety
    Olivier, B
    Pattij, T
    Wood, SJ
    Oosting, R
    Sarnyai, Z
    Toth, M
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (6-7): : 439 - 450
  • [42] Regulation of agonist efficacy at the 5-HT1A receptor
    McLoughlin, DJ
    Evans, KJ
    Clarke, WP
    FASEB JOURNAL, 2001, 15 (04): : A219 - A219
  • [43] Indoloxypropanolamine analogues as 5-HT1A receptor antagonists
    Krushinski, Joseph H., Jr.
    Schaus, John M.
    Thompson, Dennis C.
    Calligaro, David O.
    Nelson, David L.
    Luecke, Susan H.
    Wainscott, David B.
    Wong, David T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (20) : 5600 - 5604
  • [44] NOVEL MOLECULAR PROBES FOR THE 5-HT1A RECEPTOR
    LU, XJ
    GAO, YG
    GARNOVSKAYA, MN
    RAYMOND, JR
    KEBABIAN, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 5 - MEDI
  • [45] Imipramine but not 5-HT1A receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT1A and 5-HT4 receptors
    Zahorodna, A
    Tokarski, K
    Bijak, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 443 (1-3) : 51 - 57
  • [46] Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding
    Bijak, M
    Tokarski, K
    Czyrak, A
    Mackowiak, M
    Wedzony, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 305 (1-3) : 79 - 85
  • [47] 5-HT1A receptor activation: short-term effects on the mRNA expression of the 5-HT1A receptor and galanin in the raphe nuclei
    Razani, H
    Hedlund, PB
    Hansson, AC
    Fuxe, K
    Ogren, SO
    NEUROREPORT, 1997, 8 (16) : 3565 - 3570
  • [48] Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents
    Alfredo, BA
    Ofir, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 508 (1-3) : 155 - 158
  • [49] 5-HT1A receptor as a key player in the brain 5-HT system
    Popova, Nina K.
    Naumenko, Vladimir S.
    REVIEWS IN THE NEUROSCIENCES, 2013, 24 (02) : 191 - 204
  • [50] The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy
    Martinez, Ashley
    Finegersh, Andrey
    Cannon, Dara M.
    Dustin, Irene
    Nugent, Alison
    Herscovitch, Peter
    Theodore, William H.
    NEUROLOGY, 2013, 80 (16) : 1465 - 1471